Boron-exposed male workers in Turkey: no change in sperm Y:X chromosome ratio and in offspring’s sex ratio

Effects of Boron-Containing Compounds on Liposoluble Hormone Functions

Boron-containing compounds (BCC), particularly boronic acids and derivatives, are being increasingly tested as diagnostic and therapeutic agents. Some effects of BCC involve phenomena linked to the action of steroid or thyroid hormones; among these, are the effects on muscle mass or basal metabolism. Additionally, some toxicology reports on mammals, including humans, sound an alert concerning damage to several systems, among which are the negative effects on the induction of male infertility. Systemic and local mechanisms to explain changes in metabolism and impaired fertility were collected and presented. Then, we presented the putative pharmacodynamic and pharmacokinetic mechanisms involved and demonstrated in these events. In addition, it is proposed that there are adducts of some oxygenated BCC with cis-diols in fructose, an essential source of energy for sperm–cell motility, an uncoupling of sex hormone-binding globulin (SHBG) and its ligands, and the modulation of the DNA synthetic rate. These effects share the reactivity of boron-containing compounds on the cis-diols of key molecules. Moreover, data reporting no DNA damage after BCC administration are included. Further studies are required to support the clear role of BCC through these events to disrupt metabolism or fertility in mammals. If such phenomena are confirmed and elucidated, an advance could be useful to design strategies for avoiding BCC toxicity after BCC administration, and possibly for designing metabolism regulators and contraceptive drugs, among other purposes. Boronic derivatives and carboranes have been proposed and studied in this field.

Boron Exposure Assessment of Desalinated Seawater on an Island in China

This study aimed to investigate the boron level in drinking water and daily boron intake of island residents, and to have a health risk assessment of the boron exposure. One-year water boron surveillance was made through the 18 selected sampling sites (5 finished water and 13 tap water) covered by 5 water treatment plants with different water sources. We recruited 220 healthy volunteers (half men and half women) from 89 families covering all age groups living in Shengshan to provide basic information and living habits. One-third of the families attended the daily food boron intake evaluation through the double meal method for three days. In each family, only one family member provided the food samples. Urine samples were collected from all subjects to get the urine boron level. Furthermore, we used the EPA model and TDI for health risk assessments. The boron level in finished water and tap water with different sources were 0.68-1.46 mg/L and 0.62-1.26 mg/L for desalinated water, 0.30-0.39 mg/L and 0.20-0.50 mg/L for reservoir water, and 0.32-0.43 mg/L and 0.20-0.79 mg/L for mixture water. The average level of water boron intake, diet boron intake, and total boron intake was 0.113 ± 0.127 mg/d, 1.562 ± 0.927 mg/d, 1.674 ± 0.939mg/d, respectively, for the select sampling subjects. There were no significant differences in total boron intake for different age groups (1.685 ± 1.216 mg/d vs. 1.669 ± 0.793 mg/d for <45 yrs vs. ≥45 yrs, p = 0.968) and gender groups (1.754 ± 1.009 mg/d vs. 1.633 ± 0.923 mg/d for male vs. female, p = 0.735). Urine boron concentrations were similar in the two age groups (1.938 mg/g creatinine vs. 1.762 mg/g creatinine for <45 yrs vs. ≥45 yrs, p = 0.635). There were significant differences in urinary boron between males and females (1.569 mg/g creatinine vs. 2.148 mg/g creatinine, p = 0.018). The largest hazard quotient (HQ) of drinking water was 0.31, and the total boron exposures in this population were 0.03 mg/kg bw per day. The study showed that there was no possible non-carcinogenic risk of water boron exposure and lower health risk of total boron exposure to humans in this region, but its toxicity should not be ignored. The subsequent studies should strengthen the analysis of the subgroup populations.

Toxicity of boric acid, borax and other boron containing compounds: A review

Boron, often in the form of boric acid, is widely used as a flame retardant in insulation products, and although humans ingest boron through food, high exposure may lead to unwanted health effects. We assessed the toxicity of boric acid, borax and other forms of boron, after inhalation, dermal and oral exposure. After oral exposure, boron is absorbed over the gastrointestinal tract. Intact skin seems to pose a more effective barrier to boron than compromised skin. Boron excretion seems to mainly occur via the urine, although after skin exposure boron has been demonstrated in bile and gastrointestinal contents. Inhalation toxicity data are sparse, but one animal study showed reduced foetal weight after inhalation of cellulose that had a boric acid content of 20%. Skin exposure to boric acid has proven fatal in some cases, and the range of toxicity effects include abdominal as well as local effects on the skin. Fatalities from boric acid also have occurred after oral ingestion, and the endpoints in animals are weight loss and reproductive toxicity. Concerning genotoxicity studies, the overall picture indicates that boron-containing compounds are not genotoxic. There was no evidence of the carcinogenicity of boric acid in a 2-year study in mice.

Effects of boric acid on cell death and oxidative stress of mouse TM3 Leydig cells in vitro

BACKGROUND

Boron (B) is an abundant element on earth and presents at physiological pH in the form of boric acid (BA). It has both positive and negative effects on biological systems. BA and sodium borates have been considered as being toxic to the reproduction system in animal experiments. Unfortunately, the molecular mechanism underlying the toxic effects of BA is not fully understood.

METHODS

Here, we demonstrate the influence of BA on mouse TM3 Leydig cells which are male reproductive system cells targeted by BA exposure. The cytotoxicity was evaluated by MTT and NRU assays. Annexin V-FITC/PI double staining kit, mitochondria membrane potential (ΔΨm) assay kit with JC-1 and caspase-3 colorimetric assay kit were used to indicate the cell death pathway. To estimate the role of oxidative stress in BA induced toxicity, glutathione (GSH) level, catalase (CAT) and superoxide dismutase (SOD) activities were measured manually.

RESULTS

The cell viability assays showed that BA was not cytotoxic within the tested concentrations up to 1000 μM. Sub-toxic concentrations were used for detecting oxidative stress status. BA exposure was significantly reduced GSH level at 1000 μM and CAT activity in a concentration-dependent manner. However, SOD activity was increased at the tested concentrations (100-1000 μM). Moreover, ΔΨm was significantly decreased at 500 and 1000 μM of BA, while caspase-3 activity was not changed apparently.

CONCLUSION

These findings demonstrated that BA is not cytotoxic and apoptotic but may slightly induces oxidative stress in TM3 Leydig cells at higher concentrations.

Effects of boron compounds on human reproduction

Because of the high pK_a of boric acid, inorganic borates, when taken up by the human or animal organism, exist in the body almost exclusively in the form of non-dissociated boric acid. Therefore, the variety of inorganic boron compounds is commonly addressed in the toxicological literature as "boron" (B). There is a discussion concerning categorisation of inorganic boron compounds as reproductive toxins. Boron treatment of rats, mice and dogs was dose-dependently associated with testicular toxicity, characterised by inhibited spermiation at lower dose levels and by reduction of epididymal sperm counts at higher dose levels. The NOAEL for such fertility effects of boric acid in male rats (oral feeding, Sprague Dawley strain) was evaluated to be 17.5 mg B/kg bw per day. As far as developmental toxicity is concerned, oral dosing of 9.6 mg B/kg bw daily to female pregnant Sprague Dawley rats remained without effects, with foetal skeletal effects observed at higher doses. Therefore, 9.6 mg B/kg bw (oral dosing) was evaluated as NOAEL for developmental effects of boric acid. The blood level in rats, equivalent to this NOAEL, is 1270 ng B/g. As far as B-exposed humans are concerned, field studies on the effect of boron on human reproduction are possible only in a few boron-rich geographical areas. Published field studies were conducted in China's Liaoning province, the Argentinian Andes and Western Anatolia/Turkey. Particularly relevant are studies on occupationally B-exposed groups, because the potential exposure to boron is much higher in occupational compared to environmental settings. Comparison of estimated daily B exposure levels in humans and actually measured B blood levels confirms the preference of biomonitoring for exposure assessment in environmental and occupational studies. A boron blood level scaling shows that the levels of high occupational B exposures reported in China and in Turkey are compatible. Compared to the experimental B blood levels at boron-related NOAELs for male fertility and for developmental toxicity in rats, the human blood level means of the highest occupational exposure groups in China and in Turkey are lower by factors of > 4 and > 2, respectively. Basically, concentrations of B within the body that exert reproductive toxicity in humans are not reached under the conditions of human normal handling and use, including conditions of extreme occupational exposures. In consequence, all relevant results of studies into human reproductive toxicity of B are basically negative. Considering the effective doses, there is no scientific contradiction between experimental and human results of B reproductive toxicity.